The study was conceived in 2004 and revised in 2009 2009 by the ARDS Clinical Trials Network steering committee. The process committee wrote the 1st draft of the manuscript. The coordinating middle performed all the analyses. All the authors had full and independent usage of all of the vouch and data for the integrity, accuracy, and completeness of the data and analysis and the fidelity of the analysis to the protocol. AstraZeneca supplied the analysis drugs and the resources to measure blood levels of rosuvastatin. AstraZeneca had no function in the study design, study conduct, data evaluation, or data interpretation.Rahul Sarpeshkar, associate professor of electrical computer and engineering science, and his graduate pupil, Soumyajit Mandal, designed the chip to mimic the internal ear, or cochlea. The chip can be faster than any human-designed radio-frequency spectrum analyzer and also operates at lower power. The cochlea quickly gets the picture as a whole of what’s going on in the sound spectrum, said Sarpeshkar. The more I started to look at the ear, the more I noticed it’s like a super radio with 3,500 parallel channels. Sarpeshkar and his students describe their fresh chip, which they possess dubbed the radio frequency cochlea,in the June problem of the IEEE Journal of Solid-State Circuits in a paper.